Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
Abstract Lipid remodeling regulators are now being investigated as potential therapeutic targets for cancer therapy as a result of their…
